Transcripts Ovid Therapeutics Inc.

Actions

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 09/07/2026			Varia. 5j.	Varia. 1 janv.
2,600 ^USD	-4,76 %		-3,35 %	+59,51 %

08/07	Ovid Therapeutics nomme Kevin Norrett au poste de Chief Business Officer et promeut ses directeurs financier et de la stratégie	MT
08/07	Ovid Therapeutics Inc. annonce des changements au sein de sa direction	CI

14/04	Transcript : Ovid Therapeutics Inc. - Special Call
18/03	Transcript : Ovid Therapeutics Inc., Q4 2025 Earnings Call, Mar 18, 2026
03/10/25	Transcript : Ovid Therapeutics Inc. - Special Call
12/06/25	Transcript : Ovid Therapeutics Inc. - Special Call
13/11/24	Transcript : Ovid Therapeutics Inc. - Special Call
02/10/23	Transcript : Ovid Therapeutics Inc. - Special Call
10/06/21	Transcript : Ovid Therapeutics Inc. - Shareholder/Analyst Call
19/05/21	Transcript : Ovid Therapeutics Inc. Presents at RBC Capital Markets 2021 Global Healthcare Conference, May-19-2021 09:10 AM
03/03/21	Transcript : Ovid Therapeutics Inc. - Special Call
22/10/20	Transcript : Ovid Therapeutics Inc. - Special Call
25/08/20	Transcript : Ovid Therapeutics Inc. - Special Call
13/07/20	Transcript : Ovid Therapeutics Inc. - Special Call
17/06/20	Transcript : Ovid Therapeutics Inc. - Special Call
04/06/20	Transcript : Ovid Therapeutics Inc. - Shareholder/Analyst Call
23/09/19	Transcript : Ovid Therapeutics Inc. - Special Call
27/06/19	Transcript : Ovid Therapeutics Inc. - Special Call
17/12/18	Transcript : Ovid Therapeutics Inc. - Special Call
25/10/18	Transcript : Ovid Therapeutics Inc. - Special Call
06/08/18	Transcript : Ovid Therapeutics Inc. - Special Call
09/05/18	Transcript : Ovid Therapeutics Inc. Presents at 43rd Annual Deutsche Bank Healthcare Conference, May-09-2018 10:40 AM
29/03/18	Transcript : Ovid Therapeutics Inc., Q4 2017 Earnings Call, Mar 29, 2018